Laura Clague, Chief Financial Officer at Travere Therapeutics, Inc. (TVTX), sold 4,126 shares at $24.98 ($103K) on 2022-01-24, disclosed to the SEC on 2022-01-26.
Open-market sale of $103k TVTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.98 | 2,063 | $52K | 50.0% |
| 2 | $24.98 | 2,063 | $52K | 50.0% |
| Total | $24.98 avg | 4,126 | $103K | 100% |
| Filing → |
| TVTX | SELL | 2022-02-02 | $34K | — | Filing → |
| TVTX | SELL | 2022-01-12 | $206K | — | Filing → |
| TVTX | SELL | 2021-08-17 | $24K | — | Filing → |